Proactive Investors - Run By Investors For Investors

Aequus Pharmaceuticals establishes advisory board in ophthalmology

They are Dr Ike Ahmed who will become chairman and Dr Rosa Braga-Mele, who comes from the University of Toronto.
Aequus Pharmaceuticals establishes advisory board in ophthalmology
The company has established an advisory board

Aequus Pharmaceuticals Inc (CVE:AQS) told investors it had established a strategic advisory board in ophthalmology and appointed its first two members.

They are Dr Ike Ahmed of the Prism Eye Institute, who will become chairman and Dr Rosa Braga-Mele, who comes from the University of Toronto.

This board will help Aequus in determining whether a product can improve patient outcomes, integrate into a clinician's workflow, and navigate the Canadian reimbursement and commercial landscape.

"The formation of our advisory board is another step in our continued commitment to the ophthalmic space in Canada," said Doug Janzen, chairman and CEO of Aequus Pharmaceuticals.

Dr Ahmed has become world renowned for his skills and ground-breaking work in the diagnosis and surgical treatment of highly complex eye diseases including glaucoma and surgical complications

Dr Rosa Braga-Mele is a cataract specialist and educator who speaks frequently at both the national and international level on advanced surgical techniques, innovations in phacoemulsification surgery, complicated cataract cases, and IOL development.

View full AQS profile View Profile

Aequus Pharmaceuticals Inc Timeline

Related Articles

Hep C
November 22 2018
The company made positive operational progress in the year to June 30.
Lung X-Ray
October 22 2018
In its recent half-year results, the medical research investor recorded a loss after tax of £4.6mln in the six months ended June 30, less than the £5.2mln loss a year ago
researcher filling a tray of samples
December 14 2018
The company has two clinical trials underway and is well funded to achieve its immediate ambitions
Copyright © Proactiveinvestors.com, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use